About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Evaluating women’s experiences with a referral system for safe and legal abortion care on the Thailand-Burma border
Decades of conflict and stalled economic development in Burma have led to mass population displacement. For...